Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between the ages of 56 and 85 years old
- People who score 18 or above on a memory and thinking test called the Montreal Cognitive Assessment (MoCA)
- People whose level of daily functioning is not significantly affected by memory problems, as measured by a standard rating scale called the Clinical Dementia Rating (CDR) — specifically, a total score below 1 (confirm with trial site)
- People who are willing to have two blood draws for biomarker testing over the course of the study (note: as of August 2024, the spinal fluid collection procedures previously part of this trial have been removed)
- People who are willing and able to stop using prescription or non-prescription sleep aids — such as Ambien, Melatonin, Lunesta, or similar products — for the entire duration of the study, except for any medications provided by the study
- People with a Body Mass Index (BMI) below 35 at the time of joining the study
- People who are willing to bring a spouse, child, or close friend who knows them well to each of the four study visits
Who may not be able to join:
- People who have sleep apnea and do not use a CPAP machine, or who have chronic lung conditions such as COPD or emphysema
- People with a major psychiatric diagnosis such as bipolar disorder or schizophrenia
- People with a history of alcohol or drug abuse
- People diagnosed with a brain or nervous system condition such as Parkinson's disease, Lewy body disease, ALS, or multiple sclerosis
- People who have previously had a stroke or a traumatic brain injury
- People who have undergone chemotherapy in the past 2 years
- People who have been hospitalised for an injury or surgery in the past 3 months
- People whose CDR score is 1 or higher, or who have clinically significant depression or anxiety as measured by standard rating scales (confirm with trial site)
- People currently taking any of the following types of medication: Fluvoxamine (Luvox) or Fluoxetine (Prozac); Nifedipine (a blood pressure medication); blood thinners such as Warfarin, Xarelto, or Heparin; anti-seizure medications such as Gabapentin or Carbamazepine; muscle relaxants such as Valium or Baclofen; or narcotic pain relievers such as Codeine, Tramadol, or Hydrocodone
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Natalie Denburg, Ph.D., University of Iowa
Phone: 3193846050
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Episodic memory
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.